Basic Information
Persephone Biosciences Uses AI to Rapidly Develop Microbiome-Based Immunotherapies for a Cancer-Free Lifetime. Persephone's technology platform is based on diverse, inclusive, population-scale observational clinical trials, combined with advanced multi-omics analysis and machine learning, aiming to explore the complex interactions between the microbiome and the immune system.Persephone leverages synthetic biology and companion diagnostics to develop precision immunotherapies to address unmet needs and achieve more equitable treatment outcomes.
Persephone Biosciences, Inc.
SanDiego,California,United States of America
15~50 people
January 01, 2017
info@ycombinator.com
